Aligos Therapeutics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US01626L1052
USD
5.28
-0.07 (-1.31%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryAligos Therapeutics, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-1.31%
1.08%
1W
0%
1.44%
1M
-1.49%
1.32%
YTD
-43.35%
9.57%
1Y
-36.92%
25.41%
3Y
380%
70.1%
5Y
-99.18%
80.02%
10Y
%
262.13%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-24.03%
0%
-24.03%
6 Months
-49.08%
0%
-49.08%
1 Year
-36.92%
0%
-36.92%
2 Years
-49.79%
0%
-49.79%
3 Years
380.0%
0%
380.0%
4 Years
-80.97%
0%
-80.97%
5 Years
-99.18%
0%
-99.18%

Aligos Therapeutics, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary